A detailed history of New York State Teachers Retirement System transactions in Vericel Corp stock. As of the latest transaction made, New York State Teachers Retirement System holds 49,800 shares of VCEL stock, worth $2.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,800
Previous 50,100 0.6%
Holding current value
$2.75 Million
Previous $2.3 Million 8.48%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$42.25 - $53.56 $12,675 - $16,068
-300 Reduced 0.6%
49,800 $2.1 Million
Q2 2024

Jul 24, 2024

SELL
$41.71 - $52.9 $20,855 - $26,450
-500 Reduced 0.99%
50,100 $2.3 Million
Q3 2023

Oct 25, 2023

SELL
$31.69 - $39.25 $19,014 - $23,550
-600 Reduced 1.17%
50,600 $1.7 Million
Q2 2023

Jul 27, 2023

SELL
$29.0 - $38.37 $11,600 - $15,347
-400 Reduced 0.78%
51,200 $1.92 Million
Q1 2023

Apr 27, 2023

SELL
$23.85 - $31.34 $9,540 - $12,536
-400 Reduced 0.77%
51,600 $1.51 Million
Q4 2022

Jan 27, 2023

SELL
$17.65 - $27.37 $423 - $656
-24 Reduced 0.05%
52,000 $1.37 Million
Q3 2022

Oct 28, 2022

BUY
$22.62 - $32.54 $76,908 - $110,636
3,400 Added 6.99%
52,024 $1.21 Million
Q2 2022

Aug 01, 2022

BUY
$22.88 - $39.45 $70,928 - $122,295
3,100 Added 6.81%
48,624 $1.22 Million
Q1 2022

Apr 27, 2022

SELL
$31.69 - $43.29 $12,676 - $17,316
-400 Reduced 0.87%
45,524 $1.74 Million
Q4 2021

Jan 24, 2022

BUY
$35.2 - $52.6 $17,600 - $26,300
500 Added 1.1%
45,924 $1.81 Million
Q3 2021

Oct 25, 2021

BUY
$46.35 - $59.75 $19,652 - $25,334
424 Added 0.94%
45,424 $2.22 Million
Q2 2021

Jul 21, 2021

BUY
$47.2 - $67.81 $28,320 - $40,686
600 Added 1.35%
45,000 $2.36 Million
Q1 2021

Apr 22, 2021

BUY
$30.93 - $59.48 $1.37 Million - $2.64 Million
44,400 New
44,400 $2.47 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.61B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track New York State Teachers Retirement System Portfolio

Follow New York State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on New York State Teachers Retirement System with notifications on news.